BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21993190)

  • 1. Diabetes in Cushing syndrome: basic and clinical aspects.
    Mazziotti G; Gazzaruso C; Giustina A
    Trends Endocrinol Metab; 2011 Dec; 22(12):499-506. PubMed ID: 21993190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management.
    Scaroni C; Zilio M; Foti M; Boscaro M
    Endocr Rev; 2017 Jun; 38(3):189-219. PubMed ID: 28368467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing syndrome: maybe not so uncommon of an endocrine disease.
    Guaraldi F; Salvatori R
    J Am Board Fam Med; 2012; 25(2):199-208. PubMed ID: 22403201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.
    Arnaldi G; Mancini T; Tirabassi G; Trementino L; Boscaro M
    J Endocrinol Invest; 2012 Apr; 35(4):434-48. PubMed ID: 22652826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypercortisolism in pregnancy].
    Bednarek-Tupikowska G; Kubicka E
    Pol Merkur Lekarski; 2006 Feb; 20(116):232-5. PubMed ID: 16708648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess.
    León-Carrión J; Atutxa AM; Mangas MA; Soto-Moreno A; Pumar A; Leon-Justel A; Martín-Rodriguez JF; Venegas E; Domínguez-Morales MR; Leal-Cerro A
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):192-200. PubMed ID: 18702680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of glucose dysbolism in 162 cases with Cushing syndrome].
    Feng K; Lu Z; Zang M; Chen J; Wang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Jun; 22(3):266-8. PubMed ID: 12903474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of diabetes mellitus in Cushing's syndrome.
    Munir A; Newell-Price J
    Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function and cerebral assessment in patients who have Cushing's syndrome.
    Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity or Cushing's disease?
    Meloni CR
    Am Fam Physician; 1972 Jun; 5(6):92-7. PubMed ID: 4263341
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors influencing the development of glucose intolerance in Cushing syndrome.
    Kreze A; Mikulecky M; Moravcik M
    Acta Med Austriaca; 1995; 22(5):110-2. PubMed ID: 8651039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation.
    Bouzas EA; Mastorakos G; Friedman TC; Scott MH; Chrousos GP; Kaiser-Kupfer MI
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3497-500. PubMed ID: 8258505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in Cushing's syndrome.
    Chanson P; Salenave S
    Neuroendocrinology; 2010; 92 Suppl 1():96-101. PubMed ID: 20829627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in Cushing's syndrome.
    Magiakou MA; Smyrnaki P; Chrousos GP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):467-82. PubMed ID: 16980206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In what clinical settings should Cushing's syndrome be suspected?
    Bruno OD; Juárez-Allen L; Rossi MA; Longobardi V
    Medicina (B Aires); 2009; 69(6):674-80. PubMed ID: 20053613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of depression and diabetes: pathophysiological and treatment implications.
    Rustad JK; Musselman DL; Nemeroff CB
    Psychoneuroendocrinology; 2011 Oct; 36(9):1276-86. PubMed ID: 21474250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment.
    Akaza I; Yoshimoto T; Iwashima F; Nakayama C; Doi M; Izumiyama H; Hirata Y
    Hypertens Res; 2011 Oct; 34(10):1111-5. PubMed ID: 21775997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cushing syndrome. III: Cortisol or glucocorticoid excess].
    Ziegler R
    Dtsch Med Wochenschr; 1993 Aug; 118(32):1163-4. PubMed ID: 8354139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.